(RTTNews) - NextPlat Corp (NXPL, NXPLW) posted a third quarter net loss attributable to shareholders of approximately $4.2 million, or $0.22 per share, compared to a net income of approximately $3.4 million, or $0.17 per share, prior year. Gross profit margin declined to 22.9% primarily attributable to the decrease in retail prescription drug reimbursement rates in Healthcare Operations.
Consolidated revenue for the third quarter was approximately $15.4 million compared to approximately $15.3 million, last year.
The company ended the third quarter of 2024 with approximately $20.4 million in cash.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
